Search for a reference number

GHNHSFT - Redirect

Ophthalmic Diagnostic Staff, Community Diagnostic Centre

GHNHSFT - Redirect

Dear Freedom of Information Officer,

I am writing to request information under the Freedom of Information Act 2000 regarding ophthalmic diagnostic staff, Community Diagnostic Centre? (CDC) within your Trust’s Ophthalmology service.

Specifically, I am requesting the following:

Job Descriptions for all bands of ophthalmic technicians/ophthalmic photographers and their imaging lead who perform diagnostic investigations/Jobs such as: Optical Coherence Tomography (OCT) Fundus Fluorescein Angiography (FFA) Visual Acuity (VA) assessment Intraocular Pressure (IOP) measurement Corneal Topography Visual Field testing Optos widefield or fundus imaging Training and assessing ophthalmic staff Handling and managing patient images in accordance with legal, regulatory, and governance requirements Research-related ophthalmic photography

Any other ophthalmic imaging or diagnostic procedures carried out by this staff group Job Matching Reports (AFC job matching panel documentation) for these roles, including the matched national job profile used for each post.

If these staff report to an Ophthalmic Lead (or equivalent supervisory role), please provide the job description and job matching report for that lead role.

Note: If the supervisory role is held by nursing staff (e.g., Matron, Sister), this information is not required.

Also attached a questionnaire to fill in if the information is available The purpose of this request is to compare ophthalmic technician job descriptions and their associated national job profiles across NHS Ophthalmology services in England.

If any part of this request is unclear, or if the information is not held in the exact form requested, please advise and provide the closest available information.

Thank you for your time and assistance.

Yours faithfully,

Gastroenterology / Dietetic Service

GHNHSFT - Redirect

Dear Trust Officer, I am writing to request information under the Freedom of Information Act 2000. I would be grateful if you could provide the following data relating to irritable bowel syndrome (IBS) and gastroenterology/dietetic services. 1. Patient Referrals a. The number of patients diagnosed with IBS who have been referred to gastroenterology services in each of the past five years. b. The number of patients diagnosed with IBS who have been referred to dietetic services in each of the past five years. c. What criteria are used to determine whether an IBS patient is referred to gastroenterology vs dietetics? 2. Workforce a. The number of dietitians currently employed by the Trust who are trained or specialised in gut health, IBS, or gastrointestinal disorders. 3. Waiting Times and Waiting List Size a. The current average waiting time for a gastroenterology appointment, and the number of IBS patients currently on the gastroenterology waiting list and for how long. b. The current average waiting time for a dietitian appointment, and the number of IBS patients currently on the dietetic waiting list and for how long. 4. Service Capacity and Referral Pathways a. If the Trust is unable to offer appointments to all patients with IBS who are referred to gastroenterology or dietetic services, please describe the process followed. Where are these patients directed or signposted to (e.g., community services, external providers, self-management resources)? 5. Service provision: • Does the Trust offer any specialist IBS clinics or multidisciplinary clinics? • What patient education or self-management resources are provided for IBS? • Does the Trust outsource IBS-related dietetic or gastroenterology care to private or third-party providers? If so, to which providers and how many patients in each of the last five years? 6. Follow-up and discharge policy: • What is the Trust’s policy for follow-up appointments for IBS patients? • Under what circumstances are IBS patients discharged back to GP care? If any part of my request cannot be fulfilled, please provide advice and assistance as required under Section 16 of the FOI Act. I would prefer to receive this information electronically at the email address above. I understand that I am entitled to a response within 20 working days, but I appreciate that this is a detailed request and the holiday season; if an extension is required under the Act, I would be grateful if you could advise me accordingly.

GHC-27122025-645766

GHNHSFT - Redirect

Dear Trust Officer, I am writing to request information under the Freedom of Information Act 2000. I would be grateful if you could provide the following data relating to irritable bowel syndrome (IBS) and gastroenterology/dietetic services. 1. Patient Referrals a. The number of patients diagnosed with IBS who have been referred to gastroenterology services in each of the past five years. b. The number of patients diagnosed with IBS who have been referred to dietetic services in each of the past five years. c. What criteria are used to determine whether an IBS patient is referred to gastroenterology vs dietetics? 2. Workforce a. The number of dietitians currently employed by the Trust who are trained or specialised in gut health, IBS, or gastrointestinal disorders. 3. Waiting Times and Waiting List Size a. The current average waiting time for a gastroenterology appointment, and the number of IBS patients currently on the gastroenterology waiting list and for how long. b. The current average waiting time for a dietitian appointment, and the number of IBS patients currently on the dietetic waiting list and for how long. 4. Service Capacity and Referral Pathways a. If the Trust is unable to offer appointments to all patients with IBS who are referred to gastroenterology or dietetic services, please describe the process followed. Where are these patients directed or signposted to (e.g., community services, external providers, self-management resources)? 5. Service provision: • Does the Trust offer any specialist IBS clinics or multidisciplinary clinics? • What patient education or self-management resources are provided for IBS? • Does the Trust outsource IBS-related dietetic or gastroenterology care to private or third-party providers? If so, to which providers and how many patients in each of the last five years? 6. Follow-up and discharge policy: • What is the Trust’s policy for follow-up appointments for IBS patients? • Under what circumstances are IBS patients discharged back to GP care? If any part of my request cannot be fulfilled, please provide advice and assistance as required under Section 16 of the FOI Act. I would prefer to receive this information electronically at the email address above. I understand that I am entitled to a response within 20 working days, but I appreciate that this is a detailed request and the holiday season; if an extension is required under the Act, I would be grateful if you could advise me accordingly.

CIDP, Neuropathy, and GBS Diagnoses (2015–Present)

GHNHSFT - Redirect

FOI Request – CIDP, Neuropathy, and GBS Diagnoses (2015–Present) Dear FOI Team, I am writing to request information under the Freedom of Information Act 2000. Please provide the following data for the period January 2015 to the present, separated by calendar year:

1. The number of patients diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

2. The number of patients diagnosed with Guillain-Barré Syndrome (GBS)

3. The number of patients diagnosed with neuropathy-related conditions, including sensory neuropathy, motor neuropathy, and autoimmune neuropathies For each condition, please indicate:

– The total number of patients diagnosed per year
– How many were treated as inpatients and how many as outpatients
– If possible, please include data from inpatient admissions, outpatient referrals, and neurology department records.

I do not require data broken down by age, gender, or vaccine status.

Please treat this as a formal FOI request.

I understand you are required to respond within 20 working days.

Orthopaedic Trauma

GHNHSFT - Redirect

Dear Freedom of Information Officer,

I am writing to make a request for information under the Freedom of Information Act 2000. I am seeking information regarding the use of 3D printing / additive manufacturing in orthopaedic trauma within your Trust.
If any part of my request exceeds the appropriate cost or time limits, I would be grateful if you could advise me on how to refine the request in accordance with Section 16 of the Act.

Please provide any recorded information you hold for the period 1 December 2015 – 1 December 2025, where applicable.

________________________________________
FOI Question 1 – Case Numbers
Please provide the total number of orthopaedic trauma cases in which 3D printing was used at your Trust between 1st December 2015 and 1st December 2025, along with an annual breakdown of these cases.
________________________________________
FOI Question 2 – Patient Demographics
For the cases identified above, please provide the number of patients by recorded gender (male, female, other) and the number of paediatric patients (
________________________________________
FOI Question 3 – Patient-Specific vs Generic 3D Printing
Please confirm whether your Trust currently uses 3D printing for:
a) patient-specific models, and
b) generic or reusable surgical tools or guides, and
c) implants (temporary or permanent)
________________________________________
FOI Question 4 – In-House Workflow
For any 3D printing performed in-house, please indicate which stages of the workflow are carried out internally (Imaging, Segmentation, Design, Manufacture, Quality Control, Operation), according to any recorded Standard Operating Procedures or workflow documentation.
________________________________________
FOI Question 5 – Imaging Modalities
Please list the imaging modalities used for 3D printing cases (CT, MRI, X-ray), including the approximate usage rate per case where available.
________________________________________

Please provide the information in electronic format where possible.
Thank you for your time and assistance. I look forward to your response within the statutory 20 working days.
If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
If you can identify any ways that my request could be refined, I would be grateful for any further advice and assistance.
If you have any queries please don’t hesitate to contact me via email and I will be very happy to clarify what I am asking for and discuss the request, my details are outlined below.

Thank you for your time and I look forward to your response.

Straight to Test (STT) Colonoscopy

GHNHSFT - Redirect

Dear FOI Team,

I am writing to request the following information under the Freedom of Information Act 2000.

Please provide data for the period 1 January 2024 to 31 December 2024, unless otherwise specified. Straight to Test (STT) Colonoscopy Does the Trust provide Straight to Test (STT) colonoscopy services for the suspected cancer referral pathway? If STT, are they spoken to first in a clinic appointment or are they sent straight to colonoscopy without discussion?

Iron Deficiency Anaemia (IDA) Pathway Does the Trust have a specific iron deficiency anaemia (IDA) Faster Diagnostic Pathway (FDP)?

If not, please confirm which pathway IDA patients are referred to (e.g., Lower GI, Upper GI, Gastroenterology, or Colorectal). If yes, which speciality manages this? Number of referrals to the IDA pathway (01/01/2024 – 31/12/2024)

Number of colorectal cancers diagnosed via the IDA pathway (01/01/2024 – 31/12/2024). Number of IDA pathway patients seen by the Colorectal team (01/01/2024 – 31/12/2024)

Number of IDA pathway patients seen by the Gastroenterology team (01/01/2024 – 31/12/2024)

Do patients with IDA with positive FIT go to the IDA pathway or the lower GI pathway?

Lower GI Suspected Cancer Pathway Total number of Lower GI suspected cancer referrals (01/01/2024 – 31/12/2024).

Number of cancers diagnosed on the Lower GI suspected cancer referral pathway, categorised by site-specific cancer, including (but not limited to): Colorectal Small bowel NTE (Neuroendocrine) Gastric Oesophageal

Any other relevant categories Colorectal Surgery Activity Total number of referrals to Colorectal Surgery (not including lower GI cancer referrals) (01/01/2024 – 31/12/2024).

Average waiting time for a Lower GI 2-week-wait (2WW) referral to first appointment.

Average waiting time for an urgent outpatient referral to Colorectal Surgery.

Average waiting time for a non-urgent outpatient referral to Colorectal Surgery. Inflammatory Bowel Disease (IBD)

How many patients were diagnosed with inflammatory bowel disease (IBD) through the Lower GI Faster Diagnostic Pathway?

If any of the requested information is not held, please confirm this.

I would be grateful if the data could be provided in electronic format.

Thank you for your assistance. I look forward to your response within the statutory FOI timeframe.

Kind regards

Pregnancies and Spontaneous Miscarriages

GHNHSFT - Redirect

To whom it may concern,

I am writing to request the following information under the Freedom of Information Act 2000:

I would be grateful if you could provide the number of pregnancies recorded for women whose address was GL12 8DB (HMP Eastwood Park) for the years 2022, 2023 and 2024.

I would be grateful if you could also provide the number of pregnancies resulting in spontaneous miscarriage recorded for women whose address was GL12 8DB (HMP Eastwood Park) for the years 2022, 2023 and 2024.

If possible, I would greatly appreciate it if this could be provided in a spreadsheet format.
If providing all this information is not possible under the appropriate time limit, before exercising Section 12 I would ask you to recognise Section 45 of the act also requires you to advise how they can bring the request within the acceptable limit, so as not to breach Section 16 (advice and assistance).
Ahead of time, I would like to make clear I consent to any refinements to this request so that some information may be provided.

MRI Diagnostic Capacity Data

GHNHSFT - Redirect

On behalf of Merck, the healthcare company, we are currently conducting national research into access to MRI diagnostics for people with neurological conditions across NHS Trusts in England. The results will be used to identify best practice and key learnings to inform policy and planning.
Under the Freedom of Information Act 2000, I would like to request the following recorded information for your Trust. Where data is unavailable, please indicate that, and if only partial data is available, please provide what you can.

For your convenience, you can provide your answers in the tables below.

Requested information

Are your local GPs able to request neurology MRI scans at your Trust? Yes/No
Do admitted neurology patients have access to MRI 7 days a week? Yes/No
What % of neurology patients have their MRI test within 14 days from request from the most recent data available?
What % of neurology patients receive their MRI results within 14 days of the test from the most recent data available?
What % of neurology patients received a diagnosis within 6 weeks from the time the diagnostic test was sent from the most recent data available?
How many MRI scanners are there in your trust? For any of these scanners, please state the year of installation and the TESLA rating (1.5 TESLA, 3 TESLA, 7 TESLA). See table below
How many neuro-radiologists do you have in your trust?
Is there access to MRI and specialist neuroradiological opinion 24 hours a day? Yes/No
MRI scanners table
Scanner Year of installation Tesla rating
1
2
3
…
Example:
1 2017 1.5
2 2023 3

Notes
• If any of the questions is unclear, please not hesitate to get in touch
• If the Trust already publishes some or all of this information (e.g., in a disclosure log), a link or reference to the disclosure entry will suffice
• If the Trust does not hold this information in the requested level of detail, please provide any available version or summary, and indicate the level (e.g., Trust-wide totals of TESLA 1.5/3/7 scanners if you don’t have this detail per scanner)
• If some information is exempt under the Act, please specify the relevant exemption(s) and provide all non-exempt parts.

Cardiology Software and Vendor Neutral Archive Systems

GHNHSFT - Redirect, Health, IT

Good morning,
I am writing to request information under the Freedom of Information Act 2000.

Please could you provide the following details regarding your Trust’s use of digital systems in the cardiology department:

1. Does your Trust currently use any software systems to manage clinical records, diagnostics, or workflows within cardiology?

2. If yes, please provide:

a The name of the software provider and product.
b The start date and duration of the current contract.
c The expiry date or next renewal date of the contract.
d Whether the contract includes options for extension or renewal.

Additionally:

3. Does your Trust currently use a Vendor Neutral Archive (VNA) system to store and manage medical imaging or other clinical data across departments?

4. If yes, please provide:

a The name of the VNA provider and product.
b The departments where it is currently deployed.
c The start date, duration, and expiry/renewal date of the contract.
d Whether the contract includes options for extension or renewal.

I would prefer to receive the information electronically, if possible. I understand that under the Act, you are required to respond to this request within 20 working days. If any of the requested information is exempt from disclosure, please specify the exemption and provide any non-exempt information that can be released.

Thank you for your assistance.

Surgical Delays Caused by Missing/Late/Unsterilised Instruments

GHNHSFT - Redirect

(20 October 2025)

I am writing under the Freedom of Information Act 2000 to request information relating to surgical delays caused by equipment or instrument availability within your Trust.

This request aims to understand how logistical and operational factors — rather than clinical causes — may contribute to surgery scheduling challenges across the NHS.

Please provide data for 2024, and any available for 2025 to date for the following:

1️⃣ Surgical delays
• The number of operations delayed or cancelled where the recorded cause included:
o Missing or incomplete surgical instrument sets
o Late arrival of loan sets or consignment trays from suppliers
o Equipment or instrument sterilisation or cleaning faults
o Missing documentation, instructions for use (IFUs), or traceability records
If your Trust does not record these categories specifically, please provide the nearest equivalent data (e.g. “equipment failure,” “instrument availability,” or “theatre preparation delays”).

2️⃣ Delay duration
• Where available, please provide the average or total delay time (e.g. hours or days) attributed to these causes.

3️⃣ Reporting system
• If available, please confirm which system(s) your Trust uses to record and categorise surgical delays (e.g. Datix, ORMIS, Bluespier, or another).

4️⃣ Internal reports
• If available, please share any summaries, reports, or audits produced since 2023 that discuss equipment-related surgical delays, loan set management, or theatre efficiency
If it is not possible to provide all of this data within the cost or time limits set by Section 12 of the Act, please provide as much of the information as possible and advise how I may refine my request to bring it within scope.
If certain data is unavailable or not centrally recorded, please confirm this and provide any partial or relevant information held.

Referrals and Treatments for Overactive Bladder

GHNHSFT - Redirect

I am writing under the Freedom of Information Act 2000 to also request the following information:

1. The number of patients referred to your Trust for Overactive Bladder (OAB) in each of the past five calendar years, from 2020 to 2025 (year to date). Please include both internal referrals within the Trust and external referrals from primary care or other organisations.

Please provide the information broken down by calendar year.

2. The number of patients treated for OAB using each of the following modalities in each calendar year from 2020 to 2025 (year to date):
a. Intradetrusor botulinum toxin (Botox) injections
b. Sacral nerve stimulation (SNS) or tibial nerve stimulation (TNS)

Please provide this data broken down by year and treatment type.

If available, please also include whether any patients received both treatments concurrently or sequentially.

Provision of Transcranial Magnetic Stimulation (TMS).

GHNHSFT - Redirect

I was hoping you could answer the following queries in relation to provision of Transcranial Magnetic Stimulation (TMS).

1. Does the Trust provide TMS to patients in its own TMS clinics?

2. In the last 24 months, has the Trust funded TMS for any patients in external (private or neighbouring NHS) clinics?

Mortuary Practices

GHNHSFT - Redirect, Misc

I am writing to request information under the Freedom of Information Act 2000 concerning the handling and storage of deceased persons at your hospital’s mortuary.
This request is being made to all NHS hospitals with mortuary facilities located in the UK. I would be grateful if you could provide the following information for your hospital for the most recent 24-month period available:
1. The average length of time deceased individuals are kept in your hospital mortuary prior to release for burial or cremation.
2. The minimum and maximum duration any deceased individual was retained in your mortuary during that period.

3. The total number of deceased released from your mortuary, broken down by:
– Online funeral directors (those primarily operating through online platforms)
– Local/traditional funeral directors (those with a physical local presence)

4. The average duration of stay in your mortuary for deceased individuals handled by:

– Online funeral directors
– Local funeral directors

5. The total number of requests for jewellery to be removed, broken down by:

– Online funeral directors (those primarily operating through online platforms)
– Local/traditional funeral directors (those with a physical local presence)

6. The total number of requests for the deceased to be dressed for viewing in the mortuary, broken down by:

– Online funeral directors (those primarily operating through online platforms)
– Local/traditional funeral directors (those with a physical local presence)

If applicable, I would also appreciate it if you could share any internal protocols or policy documents regarding the standard retention period for deceased individuals in your care.

Minimally Invasive Cancer Therapies (MICTs)

GHNHSFT - Redirect, Misc

I am writing to request information under the Freedom of Information Act (2000).
I would be most grateful if you could please provide details on the use of Minimally Invasive Cancer Therapies (MICTs), commissioned or delivered within your Trust area during the 2024-2025 financial year. The types of treatments MICTs include are:
• Cryoablation
• Selective Internal Radiation Therapy (SIRT)
• High-Intensity Focused Ultrasound (HIFU)

Please confirm if your Trust does or does not commission any of these procedures. If so, please list the therapies involved.
In addition, if your Trust carry out any of these procedures, I would be most grateful if you could please provide me with details of the number of times each therapy was used or delivered within the 2024 – 2025 financial year.
To summarise, I am requesting the following:
1. Does your trust commission and/or deliver any of the following MICTs: Cryoablation, Selective Internal Radiation Therapy (SIRT) and High-Intensity Focused Ultrasound (HIFU)? If yes, which therapies?
2. For each therapy commissioned or delivered, how many times was it used or delivered within the 2024-2025 financial year?

Withdrawal of all NexGen Knee Replacement

GHNHSFT - Redirect, Misc

I am a journalist working for BBC Radio 4, writing to request information under the Freedom of Information Act 2000
On 15 February 2023, the Medical and Healthcare Regulatory Agency (MRHA) issued a notice advising of the withdrawal of all All NexGen Complete Knee Solution Stemmed Nonaugmentable Option Tibial Components made by Zimmer Biomet.
This was followed by an MHRA notice issued on 15th February 2023 stating that there was a higher revision rate for NexGen knee replacements compared to other knee replacements.
They identified the NexGen® Stemmed Option Tibial Components when paired with either the Legacy® Posterior Stabilized (LPS) Flex Option Femoral or the LPS Flex Gender Solutions Femoral (GSF) Option Femoral.
The MHRA advised the patients should be offered additional follow-up.
I would like to request the following information under the Freedom of Information Act 2000
From the 15th February 2023 until 13 June 2025:
1. How many patients has your Trust identified that have been implanted with the affected devices?
2. How many of these patients have been notified about this recall?
3. How many of these patients have received a follow up consultation?
4. How many of these patients have received revision surgery?
5. How many of these patients are awaiting revision surgery?

Histopathology Department

GHNHSFT - Redirect, Misc

Under the Freedom of Information Act (2000), please provide the following information:

In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.3ppm but less than or equal to 0.4ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.4ppm but less than or equal to 0.5ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.5ppm but less than or equal to 0.6ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.6ppm but less than or equal to 0.7ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.7ppm but less than or equal to 0.8ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.8ppm but less than or equal to 0.9ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.9ppm but less than or equal to 1ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 1ppm but less than or equal to 1.5ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 1.5ppm but less than or equal to 2ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that exceed 2ppm in the Trust’s Histopathology Department?

Endoscopy Traceability Software

GHNHSFT - Redirect

I am writing to request information under the Freedom of Information Act 2000 regarding the Endoscopy Traceability software currently in use within the Trust.

Could you please provide the following details:

Software Name and Supplier
The name of the current Endoscopy Traceability software in use and the details of the supplier.

Duration of Use
How long has the Trust been using this Traceability software?

Contract Start Date
The start date of the current contract for the Endoscopy Traceability software.

Contract End Date
The end date of the current contract.

Current Annual Contract Value
The Annual value of the current contract.

Procurement Framework (if applicable)
If relevant, please provide details of the procurement framework used to award the contract.

Who is responsible for managing the Endoscopy Traceability software?
Which service does this software fall under.

What machines are currently being used by your Endoscopy department?

What EWD cabinets or sterilisers are being used in your Endoscopy service.

Midwifery

GHNHSFT - Redirect

As part of a MSc Midwifery dissertation, I am investigating the number of Consultant Midwives/Consultant Midwifery Posts in the UK (including the Channel Islands and Isle of Man). While Consultant Midwives (CMs) will primarily be employed within maternity services, an increasing number of Ambulance and Community/Mental Health organisations are utilising the specialist skills of senior Midwifery clinicians so I hope this data will help us to understand the distribution and impact of CMs in all our health services.

I would therefore be grateful if you would be able to provide the following information:

– Number of Consultant Midwives (headcount AND Whole Time Equivalent (WTE)) currently employed
– Number of vacant Consultant Midwifery posts (WTE), if applicable
– Salary band paid/offered to Consultant Midwives (e.g. Band 8b or Band 8c), if applicable
– Number of Trainee/Assistant Consultant Midwives (headcount AND WTE) currently employed
– Number of vacant Trainee/Assistant Consultant Midwife posts (WTE), if applicable
– Salary band paid/offered to Trainee/Assistant Consultant Midwives, if applicable

Obstetric unit

GHNHSFT - Redirect

I would like to request information regarding your obstetric unit, under the FOIA

-To which LMNS does your trust belong to?
-Is your trust a tertiary Fetal Medicine Unit?
-Does your trust do a routine late third trimester scan for every woman in pregnancy?

Regarding growth scans in the second or third trimester:

-To calculate HC do you use HC or BPD + OFD?
-To calculate AC do you use AC or TAPD + APD?
-To plot FL centile which biometry chart do you use? (eg Chitty )
-To plot HC centile which biometry chart do you use? (eg Chitty )
-To plot AC centile which biometry chart do you use? (eg Chitty )

-What algorithm do you use to calculate Estimated Fetal Weight?
(Eg Hadlock (HC, AC, FL), Hadlock (BPD-HC-AC-FL), Hadlock (FL-AC), Warsof (BPD-AC), Persson (BPD-TAD-APAD-FL), Hansmann et al, Combs, Souka, INTERGROWTH-21ST or other)

-What centile reference chart do you use to plot the Estimated Fetal Weight?

-Does your trust use GAP-GROW?

-To measure Amniotic Fluid does your trust measure Deepest Vertical Pool or measure Amniotic Fluid Index?

-Which chart do you use to plot the amniotic fluid volume?

-When measuring Uterine Artery Doppler PI and PSV which reference centile chart do you use?
-When measuring Umbilical Artery Doppler PI and PSV which reference centile chart do you use?
-When measuring Middle Cerebral Artery Doppler PI and PSV which reference centile chart do you use?
-When measuring Ductus Venosus Doppler PI and PSV which reference centile chart do you use?

Do you use the same charts for fetal biometry, Amniotic Fluid Index and Dopplers across all hospitals in your trust and all trusts in LMNS region?

Maternity services in Gloucestershire

GHNHSFT - Redirect

Freedom of Information Request:

1. Number of post-partum referrals to the Gloucestershire Birth Anxiety and Trauma Service (or its previous incarnation as the Maternal Mental Health Service) broken down by referral source (self or professional) and by month since Jan 2021.
Why it is important: This data will be joined with information from a separate FOI to GHFT to help to give an indication of some of the wider impact and cost of the inadequate Gloucestershire Maternity Service.

2. Provide any analyses of the impact (specifically on increased demand and additional cost) on any and all services provided by Gloucestershire Health and Care Foundation Trust caused by Gloucestershire Maternity Service since Jan 2021.
Why it is important: This will help to understand some of the impact of the provision of inadequate maternity services in Gloucestershire.

3. Provide details of any discussions with the Glos ICB (or previously the CCG) or GHFT on additional demand and cost of delivery on any services provided by GHC, believed to be linked to the ‘inadequate’ CQC rating of Gloucestershire Maternity Service since Jan 2021.
Why it is important: This will help to understand the level of awareness within the ICB and GHFT of some of the impact of the provision of inadequate maternity services in Gloucestershire.

Microbiology, Virology and Molecular Tests

GHNHSFT - Redirect

I am writing to request the following information under the Freedom of Information Act 2000.

Please could you kindly complete the spreadsheet attached to provide information on the microbiology, virology and molecular tests carried out within the Pathology Laboratory at the Trust over the previous 2 calendar years (April 2023 – March 2025).

All questions relate to microbiology and virology molecular tests and traditional microbiology testing only, please do not include details for any other disciplines unless otherwise stated.

Please complete all questions where possible – if precise data is unavailable, please provide an estimate (stating that data is an estimate plus likely error margin expressed as a percentage).

If unable to complete all questions, please provide a partial response (just completing the data that you can).

Next Entries »